ISHARES TR - U.S. PHARMA ETF (IHE)

CUSIP: 464288836

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / U.S. PHARMA ETF
Total 13F shares
544,377
Share change
+93,986
Total reported value
$83,775,755
Put/Call ratio
34%
Price per share
$153.87
Number of holders
89
Value change
+$14,643,808
Number of buys
39
Number of sells
34

Quarterly Holders Quick Answers

What is CUSIP 464288836?
CUSIP 464288836 identifies IHE - ISHARES TR - U.S. PHARMA ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IHE - ISHARES TR - U.S. PHARMA ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q2 2020

As of 30 Jun 2020, ISHARES TR - U.S. PHARMA ETF (IHE) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 544,377 shares. The largest 10 holders included ROYAL BANK OF CANADA, CITADEL ADVISORS LLC, MORGAN STANLEY, BROWN ADVISORY INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, RAYMOND JAMES & ASSOCIATES, BANK OF AMERICA CORP /DE/, MURPHY CAPITAL MANAGEMENT INC, LPL Financial LLC, and Steward Partners Investment Advisory, LLC. This page lists 88 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
92
Q2 2020 holders
89
Holder diff
-3
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 Value $ Q2 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .